Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2013 by Pedro Bueno, DNA Capital is a global healthcare investment firm based in São Paulo, Brazil, and San Francisco, USA. The firm manages a portfolio of 24 companies and focuses on building leading healthcare businesses by partnering with exceptional founders and management teams.
DNA Capital invests exclusively in the healthcare sector, covering stages from pre-seed to Series E and growth equity. The firm provides capital and support to companies in healthcare, biotech, and digital health, aiming to connect and optimize healthcare businesses globally.
Notable portfolio companies include DASA, the fifth largest diagnostics company in the world, and Mafra, a leading integrated healthcare services provider in Latin America. Other investments include Alto Pharmacy, Arterys, Beep Saúde, and Clover Health.
Email your pitch deck to contact@dnacapital.com for consideration.
Yes, DNA Capital often leads investment rounds, particularly in early-stage ventures within the healthcare sector.
The firm actively participates in follow-on investments to support portfolio companies as they grow and scale.
Specific fund size details are not publicly disclosed, but the firm has a significant portfolio across various stages of investment.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.